Utah Medical Products Inc Revenue Growth Rates (UTMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Utah Medical Products Inc  (NASDAQ: UTMD)
 

UTMD's Revenue Growth by Quarter and Year

Utah Medical Products Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UTMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 8.53
1st Quarter March 8.28
FY 16.81

UTMDs Annual Revenue
Utah Medical Products Inc's Revenue in the fiscal year 2025 $ 38.00 millions
Utah Medical Products Inc's Revenue in the fiscal year 2024 $ 40.14 millions
Utah Medical Products Inc's Revenue in the fiscal year 2023 $ 50.04 millions
Utah Medical Products Inc's Revenue in the fiscal year 2022 $ 52.28 millions
Utah Medical Products Inc's Revenue in the fiscal year 2021 $ 49.05 millions




UTMD Revenue second quarter 2026 Y/Y Growth Comment
Utah Medical Products Inc reported fall in Revenue in the second quarter 2026 by -11.16% to $ 8.53 millions, from the same quarter in 2025.
The decline in the second quarter 2026 Utah Medical Products Inc's Revenue compares unfavorably to the Company's average Revenue growth of 2.88%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 155 other companies have achieved higher Revenue growth. While Utah Medical Products Inc' s Revenue decrease of -11.16% ranks overall at the positon no. 3362 in the second quarter 2026.


UTMD Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 1.09 % -25.71 % -9.2 %
3rd Quarter September - -2.04 % -21.66 % -3.47 %
2nd Quarter June -11.16 % -7.69 % -18.37 % -5.14 %
1st Quarter March -13.21 % -11.42 % -13.98 % 1.62 %
FY   - -5.31 % -19.9 % -

Financial Statements
Utah Medical Products Inc's second quarter 2026 Revenue $ 8.53 millions UTMD's Income Statement
Utah Medical Products Inc's second quarter 2025 Revenue $ 9.60 millions Quarterly UTMD's Income Statement


UTMD Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -3.54 % -6.53 % -1.44 %
3rd Quarter September - 0 % -5.77 % -1.81 %
2nd Quarter June 3.01 % 0.63 % -3.44 % 1.76 %
1st Quarter March -10.58 % 4.15 % -12.65 % -7.81 %
FY (Year on Year)   - -5.31 % -19.9 % -


Back to UTMD Growth rate Comparisons >> Back to UTMD Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #459
Overall #3362

Revenue Y/Y Growth Statistics
High Average Low
73.91 % 2.88 % -25.82 %
(Jun 30 2012)   (Dec 31 2024)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #459
Overall #3362
Revenue Y/Y Growth Statistics
High Average Low
73.91 % 2.88 % -25.82 %
(Jun 30 2012)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Utah Medical Products Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
52.76 % 0.79 % -19.4 %
(Jun 30 2011)  


UTMD's II. Quarter Q/Q Revenue Comment
Utah Medical Products Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 3.01%, to $ 8.53 millions, from $8.28 millions in the first quarter.
UTMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 55 other companies have achieved higher Revenue quarter on quarter growth. While Utah Medical Products Inc's Revenue growth quarter on quarter, overall rank is 1324.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #56
Healthcare Sector #187
Overall #1324
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #56
Healthcare Sector #187
Overall #1324
Revenue Q/Q Growth Statistics
High Average Low
52.76 % 0.79 % -19.4 %
(Jun 30 2011)  


UTMD's II. Quarter Q/Q Revenue Comment
Utah Medical Products Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 3.01%, to $ 8.53 millions, from $8.28 millions in the first quarter.
UTMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 55 other companies have achieved higher Revenue quarter on quarter growth. While Utah Medical Products Inc's Revenue growth quarter on quarter, overall rank is 1324.


Utah Medical Products Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 35.68 $ 36.75 $ 38.00 $ 37.89 $ 38.09
Y / Y Revenue Growth (TTM) -6.34 % -5.53 % -5.3 % -12.48 % -17.2 %
Year on Year Revenue Growth Overall Ranking # 3317 # 2778 # 2966 # 2306 # 2589
Seqeuential Revenue Change (TTM) -2.9 % -3.31 % 0.28 % -0.52 % -2.07 %
Seq. Revenue Growth (TTM) Overall Ranking # 2780 # 2428 # 2799 # 2087 # 2446


Cumulative Revenue growth Comment
Utah Medical Products Inc's cumulative 12 months Revenue continue to decrease, but on the faster rate at -6.34% year on year, at Jun 30 2026 compare to the -5.53% decrease at Mar 31 2026. If the Utah Medical Products Inc's fiscal year would end at Jun 30 2026, annual Revenue would be $36 millions.

In the Healthcare sector 448 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2778 to 3317.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 145
Healthcare Sector # 449
Overall # 3317

Revenue TTM Y/Y Growth Statistics
High Average Low
41.4 %
 0.77 %
-19.9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 145
Sector # 397
S&P 500 # 2780
Cumulative Revenue growth Comment
Utah Medical Products Inc's cumulative 12 months Revenue continue to decrease, but on the faster rate at -6.34% year on year, at Jun 30 2026 compare to the -5.53% decrease at Mar 31 2026. If the Utah Medical Products Inc's fiscal year would end at Jun 30 2026, annual Revenue would be $36 millions.

In the Healthcare sector 448 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2778 to 3317.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 145
Healthcare Sector # 449
Overall # 3317

Revenue TTM Y/Y Growth Statistics
High Average Low
41.4 %
0.77 %
-19.9 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 145
Sector # 397
S&P 500 # 2780




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
UTMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Utah Medical Products Inc Revenue Growth Rates (UTMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Utah Medical Products Inc (CIK 706698).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001096906-26-001210
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Utah Medical Products Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.